RankingsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cash from investing

SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】

Market cap
¥573.5B
P/E ratio
16.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2025-8,223+33.82%
Mar 31, 2024-6,145-77.05%
Mar 31, 2023-26,777-23.86%
Mar 31, 2022-35,169-34.08%
Mar 31, 2021-53,355+931.01%
Mar 31, 2020-5,175+76.32%
Mar 31, 2019-2,935-64.46%
Mar 31, 2018-8,259-70.71%
Mar 31, 2017-28,201-176.11%
Mar 31, 201637,052-160.04%
Mar 31, 2015-61,709+686.40%
Mar 31, 2014-7,847

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)